Evotec
Solution Type
Microbial Management, Antimicrobial Compound
Pathogens Addressed
Bacteria, Viruses, Fungi, Yeasts
Sectors Served
Human Health, Veterinary, AgriFood, Other
Overview
Evotec\'s infectious disease division, operating from Lyon, France , built on the former Sanofi anti-infectives unit acquired in 2018 , focuses specifically on AMR, tuberculosis, and malaria. It combines Evotec\'s drug discovery platforms with deep anti-infective expertise to develop novel antibacterial candidates through public-private partnerships, including collaborations with GARDP, CARB-X, and government funders advancing therapeutics for WHO priority pathogens.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
